{
    "nct_id": "NCT04343573",
    "official_title": "A Phase II Randomized Study Assessing the Efficacy of Proton Craniospinal Irradiation (CSI) vs Involved-field Photon Radiation Therapy for Leptomeningeal Metastases From Solid Tumor Malignancies",
    "inclusion_criteria": "* Patient with solid tumor malignancy with leptomeningeal metastases established radiographically and/or through CSF cytology\n* Patients who are candidates for radiation therapy for the treatment of leptomeningeal metastases\n* Patients of all ages\n* KPS ≥ 60 for participants ≥ 16 years old, and Lansky ≥ 60 for participants < 16 years old\n* For adult patient, the patient/ legally authorized representative is able to provide informed consent. For pediatric patient, a parent is able to provide informed consent.\n* Adequate bone marrow function:\n\n  * Hemoglobin > 8g/dL\n  * Absolute neutrophil count >1,000/mm\n  * Platelet count > 100,000/mm\n* Female subjects must either be of non-reproductive potential (i.e. pediatric patients, OR postmenopausal by history [≥ 60 years old, or with no menses for >1 year without an alternative medical cause], OR history of hysterectomy, OR history of bilateral tubal ligation, OR history of bilateral oophorectomy) or must have a negative serum pregnancy test within 2 weeks prior to starting treatment.\n* Patient at reproductive potential must agree to practice an effective contraceptive method.\nHealthy volunteers allowed\nMust have maximum age of 99 Years",
    "exclusion_criteria": "* Patient with multiple, serious major neurologic deficits per physician/investigator assessment including encephalopathy\n* Patient with extensive systemic disease and without reasonable systemic treatment options\n* Patient who is unable to undergo MRI brain and spine with gadolinium contrast\n* Previous radiotherapy to the intended treatment site that precludes developing a treatment plan that respects normal tissue tolerances\n* Pregnant or lactating women.",
    "miscellaneous_criteria": ""
}